Fact CheckerSign in

NCT06314048Enrolling by invitation

4T Sustainability Program

Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Pediatric T1D: 4T Sustainability Program.

Source: ClinicalTrials.gov · Last updated 21 May 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The goal of the 4T program is to implement proven methods and emerging diabetes technology into clinical practice to sustain tight glucose control from the onset of type 1 diabetes (T1D) and optimize patient-reported and psychosocial outcomes. The investigators will expand the 4T (Teamwork, Targets, Technology, and Tight Control) program to all patients seen at Stanford Pediatric Diabetes Endocrinology as the standard of care. Disseminating the 4T program as the standard of care will optimize the benefits of diabetes technology by lowering HbA1c, improving PROs, and reducing disparities.

Status (registry)
Enrolling by invitation
Study type
Observational
Enrollment
5000 (estimated)
First submitted
15 Feb 2024
Start date
30 May 2024
Primary completion date
31 Jan 2027
Lead sponsor
Stanford University
NCT number
NCT06314048

What you commit to

  • Study type: Observational
  • Planned participants: 5000
  • From 30 May 2024 to the primary completion date, 31 Jan 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Diabetes diagnosis other than T1D
  • Individuals with the intention of obtaining diabetes care at another clinic

Age

  • Individuals \> 21 years of age

Other

  • Individuals who do not consent to CGM use, CGM data integration, remote monitoring

Who the study is looking for

  • All individuals with a T1D diagnosis seen at the Stanford Children's Diabetes Clinic
  • Individuals who plan to receive follow-up care at the Stanford Children's Diabetes Clinic
  • Individuals who agree to wear a CGM that will connect to the RPM-care model
  • Age: six months to \< 21 years of age
  • Patient or guardian must own and operate a compatible smart device/phone to send data from the CGM into the HIPAA-compliant RPM-care model for data analysis and review by a care team member.
    • Dr. Maahs and Pediatric Endocrinology have philanthropic funds available to purchase compatible smart devices for participants who do not have a compatible smart device/phone.

Age in the registry: 6 months to 21 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Lucile Packard Children's Hospital
Coordinator of this site? Confirm its status
Palo AltoUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.